Growth • Revvity

RVTY

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity’s products and services are sold worldwide, with major markets in the US, Europe, and China.

-0,9%

CAGR Revenue 5Y

Revenue Compound Annual Growth Rate in the last 5 years.

-2,4%

CAGR Op. Income 5Y

Operating Income Compound Annual Growth Rate in the last 5 years.

3,5%

CAGR Net Income 5Y

Net Income Compound Annual Growth Rate in the last 5 years.

1,5%

CAGR EPS 5Y

Earnings Per Share Compound Annual Growth Rate in the last 5 years.

-2,4%

CAGR Normalized EPS 5Y

Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.

11,6%

CAGR OCF 5Y

Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!

Unrestricted access
Unlimited data history
Analysis videos
Quarterly highlights
Customizable financials table
Ranking
Discussions

...and much more!